Recorded on 10/9/2021
21-year-old female with rapidly progressive diffuse lymphadenopathy with biopsy proven T-cell acute lymphoblastic leukemia (T-ALL) presenting to discuss treatment options.
Summary:
- The panel recommends enrollment in a clinical trial for a young adult with newly diagnosed T-ALL as the preferred approach. Alternatively, if the patient is not a clinical trial candidate, the COG regimen with nelarabine would be a good option. The goal would be to avoid allogeneic stem cell transplant in first remission, with curative approach by chemotherapy alone.
At PrecisCa, we are dedicated to providing expert second opinions for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, treatment options, patient stories, and the latest advancements in cancer research. Whether you're a patient, caregiver, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: https://www.PrecisCa.com for more detailed information and personalized second opinions.
Stay connected with us:
Facebook: / precisca.oncology
Twitter: https://twitter.com/precisca_?lang=en
-Instagram: / precisca_oncology
-LinkedIn: / precisca
Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
21-year-old female with rapidly progressive diffuse lymphadenopathy with biopsy proven T-cell acute lymphoblastic leukemia (T-ALL) presenting to discuss treatment options.
Summary:
- The panel recommends enrollment in a clinical trial for a young adult with newly diagnosed T-ALL as the preferred approach. Alternatively, if the patient is not a clinical trial candidate, the COG regimen with nelarabine would be a good option. The goal would be to avoid allogeneic stem cell transplant in first remission, with curative approach by chemotherapy alone.
At PrecisCa, we are dedicated to providing expert second opinions for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, treatment options, patient stories, and the latest advancements in cancer research. Whether you're a patient, caregiver, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: https://www.PrecisCa.com for more detailed information and personalized second opinions.
Stay connected with us:
Facebook: / precisca.oncology
Twitter: https://twitter.com/precisca_?lang=en
-Instagram: / precisca_oncology
-LinkedIn: / precisca
Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
- Category
- Oncology

Be the first to comment